Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide in Chronic Constipation
NCT00306748Phase 2Completed
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Mar 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of linaclotide in chronic constipation (4 arms), sponsored by Ironwood Pharmaceuticals. Primary endpoint: Safety. Started Mar 2006; status: completed.
02
Drugs
linaclotide
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT00306748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306748.